Clinical and Life Sciences · 25 September 2026 to 25 September 2026 · 1 headlines · MedCity News
Phase 3 Data Could Make Roche Drug a Contender to Treat Rare Kidney Disease`
Phase 3 trial data suggest a Roche drug could become a viable treatment option for a rare kidney disease.